MERIDIAN BIOSCIENCE, INC. FDA Inspection Record
MERIDIAN BIOSCIENCE, INC. is an FDA-registered facility (FEI 1524213) located in Cincinnati, OH, US. RegDataLab tracks 3 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Nov 17, 2017: No Action Indicated (NAI)
- Inspections on record
- 3 (3 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 11, latest Dec 5, 2025
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Nov 17, 2017 | No Action Indicated (NAI) | Lack of or inadequate procedures (21 CFR 820.100(a)) |
| Jun 12, 2014 | No Action Indicated (NAI) | No citations listed |
| Mar 21, 2013 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Dec 5, 2025 | Class II | Z-1019-2026 | Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene… The affected lots show a decline in performance over time, which may lead to false-negative results. |
| Oct 7, 2025 | Class II | Z-0568-2026 | Meridian Bioscience, alethia c. Difficile, Catalog Number 480050, Nucleic Acid… and 1 more product The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume. |
| Oct 19, 2023 | Class II | Z-0519-2024 | Para-Pak Clean Vial-For the collection, transportation, preservation, and examination of… and 2 more products Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to… |
| Dec 15, 2022 | Class II | Z-1008-2023 | Revogene SARS-CoV-2_IVD real-time RT-PCR test
intended for the qualitative detection of… Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to… |
| Jun 22, 2022 | Class II | Z-1479-2022 | Revogene, Catalog no. 610210. IVD test instrument When a run is aborted, the cooling period protection does not occur and the user is able to open the lid prior to the completion of the… |
| Feb 15, 2022 | Class II | Z-0836-2022 | Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical… The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in… |
| Apr 8, 2021 | Class II | Z-1540-2021 | Revogene SARS-CoV-2
Catalog Number: 410700
IVD for real-time Reverse Transcription… and 1 more product Emergency Use Application (EUA) application withdrawn as false negative results reported |
| Feb 8, 2021 | Class II | Z-1299-2021 | The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum… Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the… |
| Dec 17, 2018 | Class II | Z-0732-2019 | PREMIER Cryptococcal Antigen, Catalog Number 602096
Product Usage:
The PREMIER… An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false… |
| Nov 8, 2016 | Class II | Z-1033-2017 | PREMIER EHEC and PREMIER EHEC Bulk. Internal testing has demonstrated that the indicated kit lots produce false positive results when tested with some broth specimens. |
FDA record score
21 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
11 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class II recall Z-1019-2026, this FEI as the recalling firm | Dec 5, 2025 | 4 x 1 | 4 |
| Class II recall Z-0568-2026, this FEI as the recalling firm | Oct 7, 2025 | 4 x 1 | 4 |
| Class II recall Z-0519-2024, this FEI as the recalling firm | Oct 19, 2023 | 4 x 0.6 | 2.4 |
| Class II recall Z-1008-2023, this FEI as the recalling firm | Dec 15, 2022 | 4 x 0.6 | 2.4 |
| Class II recall Z-1479-2022, this FEI as the recalling firm | Jun 22, 2022 | 4 x 0.6 | 2.4 |
| Class II recall Z-0836-2022, this FEI as the recalling firm | Feb 15, 2022 | 4 x 0.6 | 2.4 |
| Class II recall Z-1540-2021, this FEI as the recalling firm | Apr 8, 2021 | 4 x 0.25 | 1 |
| Class II recall Z-1299-2021, this FEI as the recalling firm | Feb 8, 2021 | 4 x 0.25 | 1 |
| Class II recall Z-0732-2019, this FEI as the recalling firm | Dec 17, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-1033-2017, this FEI as the recalling firm | Nov 8, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall Z-1941-2014, this FEI as the recalling firm | Apr 22, 2014 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing MERIDIAN BIOSCIENCE, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check MERIDIAN BIOSCIENCE, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Meridian Bioscience Inc
- Location
- Cincinnati, OH (US)
- Source
- device